Blockade of Microglial Kv1.3 Potassium Channels by the Peptide HsTX1[R14A] Attenuates Lipopolysaccharide-mediated Neuroinflammation
出版年份 2021 全文链接
标题
Blockade of Microglial Kv1.3 Potassium Channels by the Peptide HsTX1[R14A] Attenuates Lipopolysaccharide-mediated Neuroinflammation
作者
关键词
-
出版物
JOURNAL OF PHARMACEUTICAL SCIENCES
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2021-11-09
DOI
10.1016/j.xphs.2021.11.003
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Unique molecular characteristics and microglial origin of Kv1.3 channel–positive brain myeloid cells in Alzheimer’s disease
- (2021) Supriya Ramesha et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lipopolysaccharide influences the plasma and brain pharmacokinetics of subcutaneously-administered HsTX1[R14A], a KV1.3-blocking peptide
- (2021) Sanjeevini Babu Reddiar et al. TOXICON
- Pitavastatin Ameliorates Lipopolysaccharide-Induced Blood-Brain Barrier Dysfunction
- (2021) Takashi Fujimoto et al. Biomedicines
- Lipopolysaccharide induces neuroinflammation in microglia by activating the MTOR pathway and downregulating Vps34 to inhibit autophagosome formation
- (2020) Xiaoxia Ye et al. Journal of Neuroinflammation
- Microglia and Wnt Pathways: Prospects for Inflammation in Alzheimer’s Disease
- (2020) Yunying Yang et al. Frontiers in Aging Neuroscience
- The voltage-gated potassium channel KV1.3 as a therapeutic target for venom-derived peptides
- (2020) Gabor Tajti et al. BIOCHEMICAL PHARMACOLOGY
- Prolonged Plasma Exposure of the Kv1.3-Inhibitory Peptide HsTX1[R14A] by Subcutaneous Administration of a Poly(Lactic-co-Glycolic Acid) (PLGA) Microsphere Formulation
- (2020) Liang Jin et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Kv1.3 inhibition attenuates neuroinflammation through disruption of microglial calcium signaling
- (2020) Alla F. Fomina et al. Channels
- Memory-Like Inflammatory Responses of Microglia to Rising Doses of LPS: Key Role of PI3Kγ
- (2019) Trim Lajqi et al. Frontiers in Immunology
- Impact of aging, Alzheimer's disease and Parkinson's disease on the blood-brain barrier transport of therapeutics
- (2018) Yijun Pan et al. ADVANCED DRUG DELIVERY REVIEWS
- The secret life of ion channels: Kv1.3 potassium channels and proliferation
- (2018) M. Teresa Pérez-García et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer’s disease
- (2018) Srikant Rangaraju et al. Molecular Neurodegeneration
- Voltage Gated Potassium Channel Kv1.3 Is Upregulated on Activated Astrocytes in Experimental Autoimmune Encephalomyelitis
- (2018) Iva Bozic et al. NEUROCHEMICAL RESEARCH
- Microglial Activation After Systemic Stimulation With Lipopolysaccharide and Escherichia coli
- (2018) Inge C. M. Hoogland et al. Frontiers in Cellular Neuroscience
- Body temperature measurement in mice during acute illness: implantable temperature transponder versus surface infrared thermometry
- (2018) Jie Mei et al. Scientific Reports
- The voltage-gated potassium channel Kv1.3 is required for microglial pro-inflammatory activation in vivo
- (2018) Jacopo Di Lucente et al. GLIA
- Lipopolysaccharide-induced inflammation in monocytes/macrophages is blocked by liposomal delivery of Gi-protein inhibitor
- (2017) Monica Madalina Tucureanu et al. International Journal of Nanomedicine
- Neurotoxic reactive astrocytes are induced by activated microglia
- (2017) Shane A. Liddelow et al. NATURE
- Safety and pharmacodynamics of dalazatide, a Kv1.3 channel inhibitor, in the treatment of plaque psoriasis: A randomized phase 1b trial
- (2017) Eric J. Tarcha et al. PLoS One
- Physiology of intracellular potassium channels: A unifying role as mediators of counterion fluxes?
- (2016) Vanessa Checchetto et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- LPS-induced Murine Neuroinflammation Model: Main Features and Suitability for Pre-clinical Assessment of Nutraceuticals
- (2016) Miryam Nava Catorce et al. Current Neuropharmacology
- Cytokine-mediated blood brain barrier disruption as a conduit for cancer/chemotherapy-associated neurotoxicity and cognitive dysfunction
- (2016) Hannah R. Wardill et al. INTERNATIONAL JOURNAL OF CANCER
- Pulmonary Delivery of the Kv1.3-Blocking Peptide HsTX1[R14A] for the Treatment of Autoimmune Diseases
- (2016) Liang Jin et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Lipopolysaccharide-induced cytokine expression pattern in peripheral blood mononuclear cells in childhood obesity
- (2016) Yu Wu et al. Molecular Medicine Reports
- Oleoylethanolamide exerts anti-inflammatory effects on LPS-induced THP-1 cells by enhancing PPARα signaling and inhibiting the NF-κB and ERK1/2/AP-1/STAT3 pathways
- (2016) Lichao Yang et al. Scientific Reports
- Development of Highly Selective Kv1.3-Blocking Peptides Based on the Sea Anemone Peptide ShK
- (2015) Michael Pennington et al. Marine Drugs
- Blocking KV1.3 Channels Inhibits Th2 Lymphocyte Function and Treats a Rat Model of Asthma
- (2014) Shyny Koshy et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Physiological Role of Kv1.3 Channel in T Lymphocyte Cell Investigated Quantitatively by Kinetic Modeling
- (2014) Panpan Hou et al. PLoS One
- A potent and Kv1.3-selective analogue of the scorpion toxin HsTX1 as a potential therapeutic for autoimmune diseases
- (2014) M. Harunur Rashid et al. Scientific Reports
- Characterization of phenotype markers and neuronotoxic potential of polarised primary microglia in vitro
- (2013) Vibol Chhor et al. BRAIN BEHAVIOR AND IMMUNITY
- Differences in serum cytokine levels between wild type mice and mice with a targeted mutation suggests necessity of using control littermates
- (2012) Dana Briesemeister et al. CYTOKINE
- Kv1.1-dependent control of hippocampal neuron number as revealed by mosaic analysis with double markers
- (2012) Shi-Bing Yang et al. JOURNAL OF PHYSIOLOGY-LONDON
- The lymphocyte potassium channels Kv1.3 and KCa3.1 as targets for immunosuppression
- (2011) Jenny Lam et al. DRUG DEVELOPMENT RESEARCH
- Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases
- (2011) Victor Chi et al. TOXICON
- Role of Kv1.3 mitochondrial potassium channel in apoptotic signalling in lymphocytes
- (2010) Erich Gulbins et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Brain uptake of diazepam and phenytoin in a genetic animal model of absence epilepsy
- (2010) Joseph A Nicolazzo et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- CD14 and Toll-Like Receptors 2 and 4 Are Required for Fibrillar A -Stimulated Microglial Activation
- (2009) E. G. Reed-Geaghan et al. JOURNAL OF NEUROSCIENCE
- Engineering a Stable and Selective Peptide Blocker of the Kv1.3 Channel in T Lymphocytes
- (2009) M. W. Pennington et al. MOLECULAR PHARMACOLOGY
- Differential migration, LPS-induced cytokine, chemokine, and NO expression in immortalized BV-2 and HAPI cell lines and primary microglial cultures
- (2008) Ryan J. Horvath et al. JOURNAL OF NEUROCHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search